3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
51
Neoplasm Metastasis
19
Skin Neoplasms
15
Carcinoma, Renal Cell
13
Leukemia, Myeloid, Acute
12
Kidney Neoplasms
11
Leukemia
9
Neoplasms
7
Uterine Cervical Neoplasms
5
Lymphoma
5
Congenital Abnormalities
5
Breast Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Neuroblastoma
4
Myelodysplastic Syndromes
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Carcinoma, Non-Small-Cell Lung
4
Vaginal Neoplasms
2
Penile Neoplasms
2
Papillomavirus Infections
2
Oropharyngeal Neoplasms
2
Melanoma, Experimental
2
Lymphoma, Mantle-Cell
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Erythroblastic, Acute
2
Brain Neoplasms
2
Interventions
fludarabine phosphate
16
Peripheral Blood Stem Cell Transplantation
16
Cyclophosphamide
16
Mycophenolic Acid
14
Whole-Body Irradiation
13
Cyclosporine
12
Busulfan
12
Tacrolimus
11
Methotrexate
10
Antilymphocyte Serum
9
Etoposide
7
Cyclosporins
7
Melphalan
6
Sirolimus
5
Radiotherapy
5
Cytarabine
5
Filgrastim
4
Cord Blood Stem Cell Transplantation
4
ruxolitinib
3
Rituximab
3
Granulocyte Colony-Stimulating Factor
3
Alemtuzumab
3
thymoglobulin
2
sargramostim
2
Pentostatin
2
Methylprednisolone
2
Flow Cytometry
2
Carmustine
2
Carboplatin
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Myelodysplastic-Myeloproliferative Diseases
×
aldesleukin
×
Clear all
No trials found.